CCM
WVE icon

Cinctive Capital Management’s Wave Life Sciences WVE Stock Holding History

Cinctive Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-61,831
Closed -$1.05M – 528
2025
Q4 		$1.05M Sell
61,831
-48,706
-44% -$495K 0.06% 279
2025
Q3 		$809K Sell
110,537
-167,227
-60% -$1.35M 0.04% 318
2025
Q2 		$1.81M Buy
+277,764
New +$1.83M 0.1% 229
2025
Q1 		– Sell
-191,963
Closed -$2.37M – 475
2024
Q4 		$2.37M Sell
191,963
-164,345
-46% -$2.19M 0.12% 203
2024
Q3 		$2.92M Buy
356,308
+256,146
+256% +$1.53M 0.16% 194
2024
Q2 		$500K Buy
100,162
+31,756
+46% +$181K 0.02% 351
2024
Q1 		$422K Buy
68,406
+43,406
+174% +$217K 0.02% 350
2023
Q4 		$126K Buy
+25,000
New +$134K 0.01% 335

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
GP
GSK plc London $602M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Cinctive Capital Management's WVE Position: Q1 2026 in Review

Cinctive Capital Management sold out of Wave Life Sciences (WVE) in Q1 2026, closing a stake of 61,831 shares — an estimated $1.05M sold.

Cinctive Capital Management first reported a position in WVE in Q4 2023 and held it in 8 quarters. The position peaked at $2.92M in Q3 2024. 232 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Cinctive Capital Management reported no remaining Wave Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Cinctive Capital Management sold 61,831 Wave Life Sciences shares in Q1 2026, an estimated $1.05M.
  • Cinctive Capital Management first reported a position in Wave Life Sciences in Q4 2023 and held it in 8 quarters.
  • Cinctive Capital Management's Wave Life Sciences position peaked at $2.92M in Q3 2024.
  • 232 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.